Kenneth Steadman
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 5
- Colorectal Cancer Treatments and Studies 3
- Peptidase Inhibition and Analysis 3
-
- Pharmacological Effects and Toxicity Studies 3
-
- Histone Deacetylase Inhibitors Research 5
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism 3
-
- Cardiac electrophysiology and arrhythmias 3
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Susan E. BatesRobert W. RobeyOrsolya PolgárKuniaki MorisakiPrakash MistryBalázs SarkadiCsilla Özvegy‐LaczkaYasumasa Honjo
- Journals
- Cancer Research (4 papers)Molecular Cancer Therapeutics (3 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- United StatesRussiaIndia
In The Last Decade
Kenneth Steadman
26 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 96
- Oncology 611
- Pediatrics, Perinatology and Child Health 174
- Molecular Biology 543
- Cancer Research 101
- Pharmacology 58
Countries citing papers authored by Kenneth Steadman
This map shows the geographic impact of Kenneth Steadman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth Steadman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth Steadman more than expected).
Fields of papers citing papers by Kenneth Steadman
This network shows the impact of papers produced by Kenneth Steadman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth Steadman. The network helps show where Kenneth Steadman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kenneth Steadman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 2 | |
| 3 | 2018 | 53 | |
| 4 | 2015 | 34 | |
| 5 | 2015 | 24 | |
| 6 | 2014 | 17 | |
| 7 | 2013 | 14 | |
| 8 | 2013 | 0 | |
| 9 | 2012 | 1 | |
| 10 | 2010 | 33 | |
| 11 | 2009 | 43 | |
| 12 | 2009 | 22 | |
| 13 | 2009 | 64 | |
| 14 | Pharmacokinetic and biomarker analysis in a phase II trial of the HDAC inhibitor romidepsin, FK228 | 2008 | 1 |
| 15 | 2008 | 15 | |
| 16 | 2007 | 20 | |
| 17 | 2005 | 177 | |
| 18 | 2004 | 296 | |
| 19 | 1989 | 3 | |
| 20 | 1986 | 22 |
About Kenneth Steadman
Kenneth Steadman is a scholar working on Oncology, Transplantation, Pharmacology, Pathology and Forensic Medicine and Molecular Biology, having authored 28 papers that have together received 1.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (5 papers), Histone Deacetylase Inhibitors Research (5 papers), Colorectal Cancer Treatments and Studies (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Peptidase Inhibition and Analysis (3 papers), Pharmacological Effects and Toxicity Studies (3 papers), Cardiac electrophysiology and arrhythmias (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Oncology (611 citations), Pediatrics, Perinatology and Child Health (174 citations), Molecular Biology (543 citations), Cancer Research (101 citations) and Pharmacology (58 citations). Kenneth Steadman has collaborated with scholars based in United States, Russia and India. Frequent co-authors include Susan E. Bates, Robert W. Robey, Orsolya Polgár, Kuniaki Morisaki, Prakash Mistry, Balázs Sarkadi, Csilla Özvegy‐Laczka, Yasumasa Honjo, Randolph E. Patterson and Edith Speir. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology and Cell Cycle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.